Effector Therapeutics, Inc. [LWACW]

Source: 

Company Overview

Effector Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs we refer to as selective translation regulator inhibitors (“STRIs”). Translation is the process in cells whereby the production of proteins is directed by information contained in genetic sequences.